0001104659-19-071931.txt : 20191211
0001104659-19-071931.hdr.sgml : 20191211
20191211185452
ACCESSION NUMBER: 0001104659-19-071931
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191209
FILED AS OF DATE: 20191211
DATE AS OF CHANGE: 20191211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SBLENDORIO GLENN
CENTRAL INDEX KEY: 0001277478
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 191280695
MAIL ADDRESS:
STREET 1: 3 TIMES SQAURE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IVERIC bio, Inc.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208185347
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
BUSINESS PHONE: 212-845-8200
MAIL ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
FORMER COMPANY:
FORMER CONFORMED NAME: Ophthotech Corp.
DATE OF NAME CHANGE: 20070828
4
1
a4.xml
4
X0306
4
2019-12-09
0
0001410939
IVERIC bio, Inc.
ISEE
0001277478
SBLENDORIO GLENN
C/O IVERIC BIO, INC.
ONE PENN PLAZA, 35TH FLOOR
NEW YORK
NY
10119
1
1
0
0
President and CEO
Common Stock
2019-12-10
4
P
0
62500
4.000
A
176854
D
Stock Option (Right to Buy)
5.22
2019-12-09
4
A
0
190000
0
A
2029-12-08
Common Stock
190000
190000
D
Restricted Stock Units
2019-12-09
4
A
0
95000
0
A
Common Stock
95000
95000
D
These shares were acquired in a public offering of the Registrant of shares of the Registrant's common stock. The public offering price of the shares of common stock was $4.000 per share.
Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest as follows: (1) no shares underlying the option shall vest unless, for a period of twenty consecutive trading days, the average closing sale price of the Registrant's common stock is equal to or exceeds 125% of the exercise price per share of such option (the "Performance Condition"), (2) subject to satisfaction of the Performance Condition, the option shall vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in equal monthly installments through the fourth anniversary of the grant date, and (3) such stock option shall be subject to "double-trigger" acceleration of vesting upon termination of employment following a change in control of the Registrant.
Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date.
/s/ Todd Anderman, as Attorney-in-Fact for Glenn P. Sblendorio
2019-12-11